Exhibit 99.1

                                                             Investor Inquiries:
                                                             Gregory C. Thompson
                                                             (440) 329-6111

NEWS RELEASE


INVACARE CORPORATION ANNOUNCES PROPOSED RULE 144A OFFERINGS


ELYRIA,  Ohio (January 24, 2007) - Invacare  Corporation (NYSE: IVC) ("Invacare"
or the "Company")  today announced that it intends to offer its senior notes due
2015 and its convertible senior subordinated  debentures due 2027 (collectively,
the "Debt Securities") to qualified  institutional  buyers pursuant to Rule 144A
under the Securities Act of 1933, as amended (the "Securities Act"), and outside
the United States pursuant to Regulation S under the Securities Act. The Company
also is  negotiating  a new senior  secured  credit  facility and expects  that,
together  with the Debt  Securities,  the new  financing  program will result in
total  capacity  of  approximately  $700  million.  Invacare  intends to use the
proceeds of the offerings of the Debt Securities and the proposed senior secured
credit facility to refinance substantially all of its existing indebtedness.

The Debt Securities and the common shares issuable upon conversion have not been
registered  under  the  Securities  Act  or the  securities  laws  of any  other
jurisdiction  and  may  not be  offered  or sold  in the  United  States  absent
registration   under,  or  an  applicable   exemption  from,  the   registration
requirements of the Securities Act and applicable state securities laws.

This press release shall not constitute an offer to sell or the  solicitation of
offers to buy any security and shall not  constitute an offer,  solicitation  or
sale of any security in any jurisdiction in which such offer,  solicitation,  or
sale  would be  unlawful.  The  Company  gives no  assurance  that the  proposed
offerings can be completed on any terms.

Invacare  Corporation  (NYSE:IVC),  headquartered in Elyria, Ohio, is the global
leader in the manufacture and distribution of innovative home and long-term care
medical  products that promote recovery and active  lifestyles.  The Company has
5,900  associates and markets its products in 80 countries around the world. For
more information about the Company and its products, visit Invacare's website at
www.invacare.com.

This press release contains forward-looking statements within the meaning of the
"Safe Harbor"  provisions  of the Private  Securities  Litigation  Reform Act of
1995. Terms such as "will," "should," "plan,"  "intend,"  "expect,"  "continue,"
"forecast", "believe," "anticipate" and "seek," as well as similar comments, are
forward-looking  in nature.  Actual results and events may differ  significantly
from those expressed or anticipated as a result of risks and uncertainties which
include,  but are not limited to, the  following:  possible  adverse  effects of
being substantially leveraged,  which could impact our ability to raise capital,
limit our ability to react to changes in the  economy or our  industry or expose
us to interest rate risks;  changes in government  and other  third-party  payor
reimbursement  levels and practices;  consolidation of health care customers and
our competitors; ineffective cost reduction and restructuring efforts; inability
to design, manufacture, distribute and achieve market acceptance of new products
with higher functionality and lower costs;  extensive  government  regulation of
our products; lower cost imports; failure to comply with regulatory requirements
or receive  regulatory  clearance or approval for our products or  operations in
the United States or abroad;  potential product recalls;  uncollectible accounts
receivable;  difficulties  in  implementing a new Enterprise  Resource  Planning
system;  legal actions or regulatory  proceedings;  inadequate  patents or other
intellectual property protection;  incorrect assumptions  concerning demographic
trends that impact the market for our products;  the loss of the services of our
key management and personnel;  decreased  availability or increased costs of raw
materials  could  increase our costs of  producing  our  products;  inability to
acquire   strategic   acquisition   candidates   because  of  limited  financing
alternatives;  risks  inherent  in managing  and  operating  businesses  in many
different  foreign  jurisdictions;  exchange rate  fluctuations,  as well as the
risks  described  from  time to time in  Invacare's  reports  as filed  with the
Securities and Exchange Commission.  Except to the extent required by law, we do
not undertake and  specifically  decline any  obligation to review or update any
forward-looking  statements or to publicly announce the results of any revisions
to any of such statements to reflect future events or developments or otherwise.

                                       ###